FDA Drug Shortages — Page 6
Browse FDA drug shortages by generic name, company and status, with first-posted dates, from the FDA drug shortage database. RegDataLab tracks 1,814 drug shortages from official FDA sources, updated on an ongoing basis.
| Drug shortages | Details |
|---|---|
| Semaglutide Tablet | To Be Discontinued — Novo Nordisk, Inc. |
| Leflunomide Tablet | To Be Discontinued — Sanofi-Aventis U.S. LLC |
| Lorlatinib Tablet | To Be Discontinued — Pfizer Inc. |
| Dexmedetomidine Hydrochloride Injection | Current — Azurity Pharmaceuticals, Inc |
| Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release | To Be Discontinued — Amneal Pharmaceuticals |
| Dexamethasone Sodium Phosphate Injection | Current — Fresenius Kabi USA, LLC |
| Semaglutide Tablet | To Be Discontinued — Novo Nordisk, Inc. |
| Leflunomide Tablet | To Be Discontinued — Sanofi-Aventis U.S. LLC |
| Ifosfamide Injection | Current — Baxter Healthcare |
| Dexmedetomidine Hydrochloride Injection | Current — Azurity Pharmaceuticals, Inc |
| Leflunomide Tablet | To Be Discontinued — Sanofi-Aventis U.S. LLC |
| Emtricitabine Oral Solution | To Be Discontinued — Gilead Sciences, Inc. |
| Liraglutide Injection | To Be Discontinued — Teva Pharmaceuticals USA, Inc. |
| Bupivacaine Hydrochloride Injection | No longer listed by FDA — Hospira, Inc., A Pfizer Company |
| Quinapril/Hydrochlorothiazide Tablet | No longer listed by FDA — Pfizer Inc. |
| Carboplatin Injection | Current — Avyxa Pharma, LLC |
| Cisatracurium Besylate Injection | To Be Discontinued — Hospira, Inc., A Pfizer Company |
| Cromolyn Sodium Concentrate | Current — Ailex Pharmaceuticals |
| Gadoterate Meglumine Injection | To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| Activated Charcoal Oral Suspension | To Be Discontinued — Padagis US LLC |
| Alteplase Injection | To Be Discontinued — Genentech, Inc |
| Sulconazole Nitrate Solution | To Be Discontinued — Journey Medical Corporation |
| Activated Charcoal Oral Suspension | To Be Discontinued — Padagis US LLC |
| Activated Charcoal Oral Suspension | To Be Discontinued — Padagis US LLC |
| Sulconazole Nitrate Solution | To Be Discontinued — Journey Medical Corporation |
| Gadoterate Meglumine Injection | To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| Sodium Acetate Injection | Current — Milla Pharmaceuticals |
| Icatibant Acetate Injection | To Be Discontinued — Fresenius Kabi USA, LLC |
| Bupivacaine Hydrochloride Injection | Current — Hospira, Inc., A Pfizer Company |
| Quinapril/Hydrochlorothiazide Tablet | No longer listed by FDA — Pfizer Inc. |
| Activated Charcoal Oral Suspension | To Be Discontinued — Padagis US LLC |
| Gadoterate Meglumine Injection | To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| Icatibant Acetate Injection | To Be Discontinued — Fresenius Kabi USA, LLC |
| Sulconazole Nitrate Solution | To Be Discontinued — Journey Medical Corporation |
| Cisatracurium Besylate Injection | To Be Discontinued — Hospira, Inc., A Pfizer Company |
| Carboplatin Injection | Current — Avyxa Pharma, LLC |
| Activated Charcoal Oral Suspension | To Be Discontinued — Padagis US LLC |
| Gadoterate Meglumine Injection | To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| Cromolyn Sodium Concentrate | Current — Ailex Pharmaceuticals |
| Quinapril/Hydrochlorothiazide Tablet | No longer listed by FDA — Pfizer Inc. |
| Dehydrated Alcohol Injection, Solution | To Be Discontinued — Accord Healthcare Inc. |
| Iron Sucrose Injection | To Be Discontinued — Mylan Institutional, A Viatris Company |
| Bupivacaine Hydrochloride Injection | Current — Hospira, Inc., A Pfizer Company |
| Lamotrigine Tablet, Extended Release | To Be Discontinued — Par Health, Inc. |
| Tiagabine Hydrochloride Tablet | To Be Discontinued — Teva Pharmaceuticals USA, Inc. |
| Dextrose Monohydrate 5% Injection | Current — Baxter Healthcare |
| Azithromycin Tablet | To Be Discontinued — Pfizer Inc. |
| Palbociclib Capsule | To Be Discontinued — Pfizer Inc. |
| Lamotrigine Tablet, Extended Release | To Be Discontinued — Par Health, Inc. |
| Aprepitant Oral Powder for Suspension | To Be Discontinued — Merck Sharp & Dohme LLC |